Cost-effectiveness of community-based repurposed therapies for COVID-19 in the PRINCIPLE trial

May Ee Png, Victoria Harris, F. D. Richard Hobbs, Paul Little, Ly-Mee Yu, Christopher C. Butler, Stavros Petrou

Open source

DOI
10.1186/s12962-026-00809-x
Published
2026-08-01
Container
Cost Effectiveness and Resource Allocation
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12962-026-00809-x,
  title = {Cost-effectiveness of community-based repurposed therapies for COVID-19 in the PRINCIPLE trial},
  author = {May Ee Png and Victoria Harris and F. D. Richard Hobbs and Paul Little and Ly-Mee Yu and Christopher C. Butler and Stavros Petrou},
  year = {2026},
  journal = {Cost Effectiveness and Resource Allocation},
  doi = {10.1186/s12962-026-00809-x},
  url = {https://doi.org/10.1186/s12962-026-00809-x}
}

RIS

TY  - JOUR
TI  - Cost-effectiveness of community-based repurposed therapies for COVID-19 in the PRINCIPLE trial
AU  - May Ee Png
AU  - Victoria Harris
AU  - F. D. Richard Hobbs
AU  - Paul Little
AU  - Ly-Mee Yu
AU  - Christopher C. Butler
AU  - Stavros Petrou
PY  - 2026
JO  - Cost Effectiveness and Resource Allocation
DO  - 10.1186/s12962-026-00809-x
UR  - https://doi.org/10.1186/s12962-026-00809-x
ER  - 

APA

Png, M. E., Harris, V., Hobbs, F. D. R., Little, P., Yu, L., Butler, C. C., & Petrou, S. (2026). Cost-effectiveness of community-based repurposed therapies for COVID-19 in the PRINCIPLE trial. Cost Effectiveness and Resource Allocation. https://doi.org/10.1186/s12962-026-00809-x

Source records